Navigation Links
Today's Research: Life Technologies, Opko Health, Medicines, and DaVita
Date:7/25/2013

LONDON, July 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, July 24, 2013, shares in the healthcare sector ended mostly lower, tracking the broader market which also closed in the red. The major movers in the sector included Life Technologies Corp. (NASDAQ: LIFE), Opko Health Inc. (NYSE: OPK), The Medicines Company (NASDAQ: MDCO), and DaVita Healthcare Partners Inc. (NYSE: DVA). AAAResearchReports.com has completed their technical analysis on LIFE, OPK, MDCO, and DVA and these free reports are accessible by registering at:

http://www.aaaresearchreports.com/register/  

Shares in Life Technologies Corp. ended slightly lower on Wednesday, finishing at $74.52, down 0.07% from its previous closing price. The company's shares fluctuated between $74.52 and $74.73. A total of 1.69 million shares were traded which is below the daily average volume of 1.79 million. Life Technologies' shares are currently trading near their 52-week high of $74.81. The stock has gained 0.70% in the last one month and 1.11% in the last three months. Sign up for free technical research on LIFE at:

http://www.AAAResearchReports.com/LIFE072513.pdf

Opko Health Inc.'s stock fell sharply on Wednesday, tracking losses in the broader market. The company's shares ended the day 1.94% lower at $7.57 after fluctuating between $7.47 and $7.77. A total of 1.86 million shares were traded which is above the daily average volume of 1.53 million. Despite Wednesday's pullback, Opko Health's shares have gained 9.39% in the last one month and 8.76% in the last three months, hence outperforming the S&P 500 during the respective periods. Moreover, the stock is currently trading near its 52-week high of $7.83. Be sure to read our latest technical research on OPK by registering at:

http://www.AAAResearchReports.com/OPK072513.pdf

Shares in The Medicines Company tumbled on Wednesday, ending the session 5.05% lower at $29.73 after fluctuating between $29.52 and $32.60. A total of 1.81 million shares were traded which is below the daily average volume of 758,839. The company's shares have fallen by 7.18% in the last one month and 11.15% in the last three months as compared to a gain of 7.17% and 6.79% in the S&P 500 during the respective periods. The stock is trading above its 200-day moving average. Sign up and read the complimentary report on MDCO at:

http://www.AAAResearchReports.com/MDCO072513.pdf

DaVita Healthcare Partners Inc.'s stock edged lower on Wednesday, tracking losses in the broader market. The company's shares oscillated between $117.04 and $118.97. A total of 538,902 shares were traded which is below the daily average volume of 1.00 million. DaVita's shares have fallen by 4.43% in the last one month and 3.56% in the last three months. However, the stock is trading slightly above its 200-day moving average. The free report on DVA can be downloaded by signing up now at:

http://www.AAAResearchReports.com/DVA072513.pdf

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.



'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
2. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
3. Graphene Research: Trapping light in a carbon net
4. A milestone in nanoparticle research: Nanoparticle test handbook sets the standards
5. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
6. Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
7. DNA Sequencing: Technologies, Markets and Companies - 2013 Report
8. Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
9. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
10. Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
11. mPhase Technologies, Inc. Commencing Discussions with Major European Drug Company for Drug Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Oxford Gene Technology ... NGS panel range with the launch of the SureSeq myPanel™ ... of variants in familial hypercholesterolemia (FH). The panel delivers single ... a single small panel and allows customisation by ,mix and ... exons for LDLR , P C ...
(Date:12/8/2016)... Worcester, Mass (PRWEB) , ... December 08, 2016 ... ... KbioBox genetic data bioInformatics portal. In response to client demand KbioBox developed a ... gene edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Francisco, CA (PRWEB) , ... December 08, 2016 ... ... Oculus as finalists in the World Technology Awards. uBiome is one of just ... received across all categories. , In addition to uBiome, companies nominated as finalists ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):